# Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

> **NCT01148160** · — · TERMINATED · sponsor: **Asan Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Invasive Fungal Infection

## Interventions

- **DRUG:** voriconazole

## Key facts

- **NCT ID:** NCT01148160
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148160, "Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01148160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*